About
Research
Patient Care
Education & Training
Community
Oct 17, 2025
Member, Michael Demetriou, MD, PhD - New Glycan-Based Diagnostic May Refine Cancer Detection and Treatment
GlyTR Therapeutics, co-founded by Demetriou and his former postdoctoral fellow Raymond W. Zhou, is advancing both the therapeutic and diagnostic platforms
Oct 16, 2025 | NRG Oncology
Member, Alexandre Chan, PharmD, MPH - Receives NRG NCORP Pilot Project Funding for 2025-2027
Investigating riluzole’s impact on preventing neurocognitive decline and maintaining BDNF levels in chemotherapy patients.
Cancer In Focus - Events, Funding Opportunities, Announcements, & News
Events, Funding Opportunities, Announcements, & News
October 15, 2025
Oct 15, 2025 | UC Irvine School of Medicine
Member, Munjal Acharya, PhD - UC Irvine study identifies a new approach to protect the brain during radiation therapy
“We’ve identified a new, targeted way to protect the brain from the harmful side effects of cranial radiation therapy, a standard of care for brain cancers that often causes irreversible cognitive decline."
Oct 13, 2025
Member, Cholsoon Jang, PhD - Scientists crack code on how dietary fiber shields your body from harmful sugar damage
UC Irvine researchers discover inulin fiber trains gut bacteria to block fructose before it harms the liver
Oct 10, 2025
Member, Cholsoon Jang, PhD - The common vegetables that can slow or even reverse dangerous liver disease
“We found that consuming a type of dietary fibre called inulin, abundant in vegetables, changes the bacteria in the gut to promote the consumption of harmful dietary fructose"
Member, Ariana Nelson, MD - Basic Science, School of Medicine Achievement Award
Announcement from the UC Irvine School of Medicine, Office of the Dean
Oct 09, 2025
Misako Nagasaka, MD, PhD - Implications of the ALINA Trial: Is It Time to Skip Adjuvant Chemotherapy in ALK-Positive NSCLC?
Results from the ALINA trial challenge the need for chemo in ALK-positive lung cancer treatment
Member, Michael Demetriou, MD, PhD - Unique Immunotherapy Could be the ‘Holy Grail’ for a Wide Range of Cancers
“This novel technology may, for the first time, allow the widespread application of targeted T-cell therapy to solid tumours, which is the ‘holy grail’ in the immuno-oncology field.”
Oct 08, 2025
Member, David Richardson, PhD - Solid ideas and misinformation compete at Irvine’s nuclear waste session
Independent experts explore the realistic risks posed by the accidental release of radiation from spent nuclear fuel